R&D Trends

Venture capital funding for biotech soars 46%

Wednesday, July 20, 2011 01:52 PM

Venture capital funding in biotechnology companies jumped 46% in the second quarter, as investors looked to replenish their portfolios after an increase in acquisitions and initial public offerings, according to Bloomberg News.

More... »

Maine institute to shut down its centerpiece research

Tuesday, July 19, 2011 01:10 PM

What was supposed to have been a major biomedical research center in Maine when it was unveiled in 2005 is shutting down the centerpiece of its program in September due to lack of public and private funding, according to the Bangor Daily News. The Maine Institute for Human Genetics and Health will no longer carry out its primary purpose, which was to explore the links between environmental exposures to arsenic, radon and other toxic materials and cancer.

More... »

University of Delaware partners with Fraunhofer USA

Monday, July 18, 2011 09:59 AM

The University of Delaware and biotech company Fraunhofer USA have forged a new six-year partnership the university describes as a win-win-win: a win for the university, a win for Fraunhofer and an economic win for the state of Delaware, according to NewsWorks.

More... »

UBC’s new Bracket division makes Texas ePRO company Arrowhead its first acquisition

Monday, July 18, 2011 08:00 AM

Bracket, a division of United BioSource Corp. (UBC) established just last month, has made its first acquisition: Arrowhead Electronic Healthcare, a privately-held, Austin, Texas-based electronic patient-reported outcome (ePRO) technologies company. The terms were not disclosed.

More... »

Survey: U.S. M&A activity likely to increase

Thursday, July 14, 2011 12:45 PM

U.S. drug makers are likely to step up their acquisition activities in a bid to find new therapies, and they have the cash to do so, according to a survey by KPMG reported by Pharma-Times.

More... »

Survey: Biopharmaceutical industry needs innovation

Tuesday, July 12, 2011 12:12 PM

A new Economist Intelligence Unit survey sponsored by CRO Quintiles highlights the urgent need for biopharmaceutical industry innovation. The global survey comes as the biopharma sector reaches the patent cliff—this year and next, seven of the world’s 15 top-selling drugs, accounting for nearly $50 billion in sales in 2009, will go off-patent.

More... »

Merck Serono changes R&D organizational structure

Thursday, July 7, 2011 02:02 PM

Merck Serono, a division of Merck of Darmstadt, Germany, is putting a new organizational structure for research and development into effect. Two dedicated groups, focusing on different stages of pharmaceutical innovation (pre- and post- proof-of-concept), will be created as a first step in redesigning Merck Serono's R&D model.

More... »

China to spend billions on biotech development

Tuesday, July 5, 2011 12:27 PM

China will spend $308.5 billion on science and technology, making biotechnology a major priority in the next five years, said Chinese State Councilor Liu Yandong, according to China Daily. 

More... »

Report: Clinical trials market growing rapidly

Tuesday, July 5, 2011 12:16 PM

A report by London-based visiongain predicts worldwide clinical trial services revenues will reach $32.73 billion in 2015. Revenues for CROs totaled $21.69 billion in 2010, according to Pharma Clinical Trial Services: World Market 2011-2021.

More... »

Clinical research continues to grow in India

Tuesday, July 5, 2011 12:02 PM

The clinical research industry in India is expected to employ 50,000 professionals over the next five years, according to Indian trade association ASSOCHAM, PharmaTimes reported.

More... »